1994
DOI: 10.1111/j.1476-5381.1994.tb13167.x
|View full text |Cite
|
Sign up to set email alerts
|

Mediation of most atypical effects by species homologues of the β3‐adrenoceptor

Abstract: 1 A wide panel of compounds acting on 1-adrenoceptors active either in mammalian heart or in rodent digestive tract 3 This pharmacological analysis further established that the 13-adrenoceptor is the prototype of the adipose tissue atypical P-adrenoceptor, since these receptors share a number of pharmacological properties which differ strikingly from those of P13-and 132-adrenoceptors: low affinities for conventional 13-adrenoceptor agonists and antagonists, high potencies for novel compounds active in adipo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

6
60
0

Year Published

1995
1995
2014
2014

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 93 publications
(67 citation statements)
references
References 38 publications
(57 reference statements)
6
60
0
Order By: Relevance
“…Partial agonism at the cloned human, rat, and murine β 3 -adrenoceptor was also reported from other studies (Blin et al 1994;Liggett 1992). Accordingly, CGP 12,177 was also only a partial agonist for relaxation of isolated rat bladder strips, an effect not antagonized by low propranolol concentrations (Frazier et al 2006;Longhurst and Levendusky 1999).…”
Section: Adrenaline and Noradrenalinesupporting
confidence: 77%
See 4 more Smart Citations
“…Partial agonism at the cloned human, rat, and murine β 3 -adrenoceptor was also reported from other studies (Blin et al 1994;Liggett 1992). Accordingly, CGP 12,177 was also only a partial agonist for relaxation of isolated rat bladder strips, an effect not antagonized by low propranolol concentrations (Frazier et al 2006;Longhurst and Levendusky 1999).…”
Section: Adrenaline and Noradrenalinesupporting
confidence: 77%
“…Another study measuring cAMP accumulation in intact cells confirmed the rank order of potency of β 3 >β 2 >β 1 , but BRL 37,344 was an agonist for all three human subtypes, and the difference in potency between the subtypes was less than ten-fold (Tate et al 1991). Studies including only β 3 -adrenoceptors reported BRL 37,344 to be a full agonist for cAMP accumulation in intact CHO cells at human and mouse but a partial agonist at rat β 3 -adrenoceptors (Blin et al 1994;Liggett 1992). BRL 37,344 has similar affinity for both splice variants of the murine β 3 -adrenoceptor, but its effects, similar to that of many other agonists, are somewhat lower at the β 3b -compared with the β 3a -adrenoceptor, as the former couples to both G s and G i proteins (Hutchinson et al 2002).…”
Section: Adrenaline and Noradrenalinementioning
confidence: 75%
See 3 more Smart Citations